Kennedy Giulia C
- SEC CIK
- 0001769333
No open-market purchases or sales filed in the past year.
Current role at each company
- VCYT Veracyte, Inc.Chief Scientific & Med Officeras of Dec 8, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kennedy Giulia C as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2022 (view filing) | Dec 6 | 2 days | Kennedy Giulia CChief Scientific & Med Officer | SSale | −1.02K | $27.03 | −$27.7K | −1.5%66.0K after | |
| Nov 15, 2022 (view filing) | Nov 11 | 4 days | Kennedy Giulia CChief Scientific & Med Officer | SSale | −2 | $29.34 | −$58.68 | 0.0%68.0K after | |
| Nov 8, 2022 (view filing) | Nov 4 | 4 days | Kennedy Giulia CChief Scientific & Med Officer | SSale | −1.02K | $25.00 | −$25.6K | −1.5%68.0K after | |
| Aug 9, 2022 (view filing) | Aug 5 | 4 days | Kennedy Giulia CChief Scientific & Med Officer | SSale | −1.03K | $26.54 | −$27.3K | −1.4%70.0K after | |
| Mar 9, 2022 (view filing) | Mar 4 | 5 days | Kennedy Giulia CChief Scientific & Med Officer | SSale | −23.0K | $25.12 | −$578.5K | −27.3%61.4K after | Amended3 lots |
| Dec 8, 2021 (view filing) | Dec 6-7 | 2 days | Kennedy Giulia CChief Scientific & Med Officer | SSale | −15.4K | $37.71 | −$579.1K | −24.3%47.9K after | 5 lots |
| Sep 9, 2021 (view filing) | Sep 7-8 | 2 days | Kennedy Giulia CChief Scientific & Med Officer | SSale | −13.5K | $50.55 | −$680.2K | −21.2%50.0K after | 3 lots |